Breast Cancer Core Needle Biopsy Market Size is valued at USD 697.3 Mn in 2023 and is predicted to reach USD 1,042.3 Mn by the year 2031 at a 5.34% CAGR during the forecast period for 2024-2031.
A biopsy is a confirmatory procedure that helps in early cancer/tumour diagnosis, resulting in faster recovery, higher survival rates, and lower rates of morbidity and mortality. A Breast Cancer Core Needle Biopsy is a less invasive alternative to surgical biopsies and can provide valuable information to guide treatment decisions. Medical practitioners recommend a breast biopsy for an early diagnosis of breast cancer. Many public and private organizations, businesses, and healthcare facilities are developing creative campaigns to increase public knowledge about breast cancer and the advantages of early detection for overall health. Raising breast cancer awareness was the initial goal of India's extensive Pink Chain Campaign.
Furthermore, it is anticipated that rising R&D spending will promote market expansion. With the advent of highly advanced, minimally invasive breast biopsy technologies, hitherto unrealized business opportunities are expected to manifest. Moreover, rising global breast biopsy rates and an ageing female population
The breast cancer core needle biopsy market is segmented on the basis of Technology as well as End-Use. According to Technology, the market is segmented as MRI-based breast biopsy, ultrasound-based breast biopsy, mammography-based (stereotactic) breast biopsy, CT-based breast biopsy and other image-based breast biopsy. As per the End-Use, the market is segmented into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies and academic & research institutes.
The cut-based breast biopsy category is expected to hold a major share of the global breast cancer core needle biopsy market in 2022. The increase in growth is ascribed to the expanding accessibility of Technology and the increasing technological breakthroughs in CT breast biopsy. Additionally, it is predicted that stepping up research and development efforts will help the industry thrive. It has also been demonstrated that FDG PET/CT and FES PET/CT can improve the diagnostic and therapeutic options for metastatic breast cancers.
The Hospital and diagnostic laboratory segment are projected to grow at a rapid rate in the global breast cancer core needle biopsy market. A favourable environment for segment expansion is anticipated, given the rising number of patient visits to hospitals and the increased uptake of innovative tools and Technology in facilities. Collaboration between hospitals and diagnostic laboratories is vital for a seamless workflow in breast cancer core needle biopsy procedures. Timely communication and efficient sample processing contribute to faster diagnosis and treatment initiation. The integration of core needle biopsy services within these healthcare settings reflects the commitment to advancing diagnostic capabilities and improving patient outcomes in the realm of breast cancer care.
The North American breast cancer core needle biopsy market is expected to hold the maximum market revenue share in the near future. The region's significant market leadership can be attributed to its sophisticated healthcare systems, vast research capacity, and targeted patient awareness campaigns. These factors all enhance the early detection and efficient treatment of breast cancer. Prominent diagnostic and medical facilities in the US and Canada have long emphasized the value of routine screenings.
In addition, Asia Pacific is estimated to grow at a rapid rate in the global Breast Cancer Core Needle Biopsy market. The integration of AI into diagnostic procedures is a crucial component of APAC's leadership in breast cancer core needle biopsy procedures. AI-powered technologies are being utilized throughout the region to help pathologists interpret biopsy data more precisely while minimizing subjectivity and potential errors. This technical development strengthens the region's dedication to creative solutions for improved healthcare outcomes while also improving diagnostic accuracy.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 697.3 Mn |
|
Revenue Forecast In 2031 |
USD 1,042.3 Mn |
|
Growth Rate CAGR |
CAGR of 5.34 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Technology, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Intact Medical Corporation, Ethicon Surgical Technologies, Galling SRL, Leica Biosystems Nussle GmbH, Hologic, Inc, Argon Medical Devices, Encapsule Medical Devices LLC., Cook Medical Incorporated, Becton Dickinson and Company, C.R. Bard, Inc., Zenalux Biomedical, Inc., F. Hoffmann-La Roche Ltd., OncoCyte Corporation, Laboratory Corporation of America Holdings (LabCorp), Scion Medical Technologies, Planmed Oy, Aurora Imaging Technology Inc., Carestream Health, Cardinal Health, PerkinElmer, QIAGEN, Thermo Fisher Scientific, Medtronic, Danaher Corporation, Others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Breast Cancer Core Needle Biopsy Market By Technology
Breast Cancer Core Needle Biopsy Market By End-use
Breast Cancer Core Needle Biopsy Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
